Translate signals into outcomes
We connect commercial strategy, experience design, and governed AI into one operating system — so biopharma signal converts into measurable outcomes.
One arc, end to end — signal, system, outcomes.
Separate signal from noise across claims, beliefs, behavior, and market data.
Convert that signal into strategy, experience, and governed AI in one integrated system.
Drive HCP adoption, patient pathways, and lifecycle performance.
Biopharma commercial is more connected than ever.
Strategy, experience, and AI now inform each other in real time. The organizations that build these as one system — rather than three separate workstreams — are the ones that convert signal into sustained commercial performance.
Strategy that activates
Commercial strategy is most powerful when it's designed to move — directly connected to experience architecture and the AI systems that execute it in the field.
Experience that measures
HCP and patient experiences designed from commercial objectives — with measurement built in from the start, so every touchpoint compounds over time.
AI that governs itself
AI that earns trust by design — governed, auditable, and connected to the commercial logic it's meant to serve. Intelligence that improves with every cycle.
The window is compressing
First-mover advantage now belongs to organizations that connect intelligence, experience, and execution before launch — not in response to the first quarter's data.
Three disciplines.
One operating system.
Commercial strategy, experience design, and governed AI — designed together, delivered by one team, measured against one outcome.
Every AI system BeCon designs has human judgment at the center — transparent, auditable, and connected to the commercial logic it serves. Governance is what makes AI defensible to legal, compliance, and the C-suite.
We meet you where you are.
Every engagement is scoped to where you are. Every output is designed to compound forward.
Pre-Launch
Signal audit · Cohort intelligence · Launch blueprint. A two-week structured analysis with a clear owned output.
Active Launch
Performance diagnostic · Governed AI activation · AI workflow solutions · Outcomes measurement. Plugged into your in-market system without disruption.
Portfolio Scale
Portfolio signal architecture · AI governance framework · Operating model alignment across multiple assets.
Named deliverables. Owned by you.
Every engagement ends with something you own, operate, and build on — across oncology, rare disease, specialty, CNS, and cell & gene therapy.
The signal is there.
The system that converts it
is what we build.
Every biopharma asset deserves a commercial system built from the start to connect strategy, experience, and intelligence into one compounding arc.
Schedule a conversation